(Q53077825)

English

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.

scientific article published on 15 January 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

chemoradiotherapy

0 references

phase II clinical trial

0 references

adaptive radiation therapy

0 references

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Krzysztof Skladowski

5

object named as

Krzysztof Skladowski

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Jordi Giralt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jose Trigo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Mahmut Ozsahin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Georges Hatoum

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jean-Francois Daisne

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alejandro César Yunes Ancona

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Anthony Cmelak

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Ricard Mesía

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alicia Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kelly S Oliner

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Ari VanderWalde

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

15 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

221-232

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25596659%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal allocation for the comparison of proportions.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus and survival of patients with oropharyngeal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971200-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53077825&oldid=2190785593"